Skip to main content
. Author manuscript; available in PMC: 2015 Jun 1.
Published in final edited form as: Int J Cancer. 2013 Dec 12;134(11):2663–2673. doi: 10.1002/ijc.28601

Figure 3. Multimodal in vivo and ex vivo imaging of an orthotopic tongue tumor.

Figure 3

7D12 is specifically taken up in the oral squamous cell carcinoma of the tongue. Mice bearing OSC-19-luc2-cGFP human xenografts were intravenously injected with 25µg of 7D12, R2 and 800CW. After 24 hours fluorescent images were obtained with the IVIS spectrum and the intraoperative camera system (FLARE).

A. In vivo: bioluminescence brightfield merge image (left), NIR fluorescence brightfield merge IVIS image of 7D12-800CW (middle) and NIR fluorescence color merge FLARE image (right) Ex vivo: GFP brightfield merge image (left), NIR fluorescence brightfield merge IVIS image of 7D12-800CW (middle) and NIR fluorescence color merge FLARE image (right)

B. In vivo: Fluorescent imaging of a tongue tumor 24 hours after administration of 7D12-800CW (left), R2-800CW (middle) and 800CW (right). Ex vivo: Fluorescent imaging of a tongue tumor 24 hours after administration of 7D12-800CW (left), R2-800CW (middle) and 800CW (right). Images were obtained with the intraoperative camera system (FLARE)